Wikidata

(Q53633582)

English

An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.

scientific article

In more languages

Statements

title
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25628399
retrieved
16 May 2018
reference URL
http://europepmc.org/abstract/MED/25628399
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53633582&oldid=1080882477"